Skip to main content
Clinical Trials/NCT01330134
NCT01330134CompletedPhase 4

Comparison of Two Lidocaine Administration Techniques

University of Chicago1 site in 1 country481 target enrollmentStarted: February 2011Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 4
Status
Completed
Enrollment
481
Locations
1
Primary Endpoint
Pain Assessment: Overall

Study Overview

Brief Summary

The objective of our study is to determine if technique of lidocaine administration can decrease pain perception.

Hypothesis: There will be a significant difference in pain perception between patients who are given lidocaine on the skin surface prior to subcutaneous injection and patients who are given only subcutaneous injection by standard approach.

Detailed Description

This is a single center prospective, randomized, blinded study assessing pain perception following 2 different lidocaine administration techniques in subjects who have planned medical procedures requiring local injection of lidocaine. Subjects will be approached and consented to participate in the study. They will be interviewed after the scheduled medical procedure to assess their pain using validated pain scores. An investigator who is not present for the procedure and blinded to the randomization will gather data regarding perceptions of pain from the entire procedure.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Adult patients refered to the University of Chicago Medical Centers Procedure Service for a planned medical procedure requiring local injection of lidocaine.

Exclusion Criteria

  • Patient who lack decisional capacity to consent
  • Patients who lack the ability to answer questions in english using pain scales

Arms & Interventions

lidocaine onto skin prior to lidocaine subcutaneous injection

Experimental

1-2ml of 1% lidocaine dripped onto the surface of the skin immediately prior to subcutaneous injection of 1% lidocaine.

Intervention: lidocaine (Drug)

lidocaine subcutaneous injection alone

Active Comparator

1% lidocaine subcutaneous injection alone by standard approach

Intervention: lidocaine (Drug)

Outcomes

Primary Outcomes

Pain Assessment: Overall

Time Frame: post procedure (day 1)

Visual analog scale (VAS). This is a standardized analog scale with scores from 0-100. It measures level of pain with 0 meaning no pain and 100 meaning the most extreme level of pain. Higher values refer to a worse outcome.

Secondary Outcomes

  • Pain Assessment: Lidocaine Injection(post procedure (day 1))
  • Pain Assessment: During Procedure(post procedure (day 1))

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Comparison of Two Lidocaine Administration... | Clinical Trial